Advancing cancer research through artificial intelligence

April 13, 2018, University of Montreal
Credit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer Center

The sequencing of 20,000 human genes has produced an immense amount of data that must now be deciphered. Sébastien Lemieux, a bioinformatics specialist at Université de Montréal's Institute for Research in Immunology and Cancer, has begun doing so to advance cancer research. "Artificial intelligence helps us analyze data," he said in an interview.

Lemieux is using samples taken from 482 patients with a specific form of – acute myeloid leukemia – to try to pin down the genetic profile of cancer cells. "We're still a long way from developing a for the tools we're building, which combine artificial intelligence with genetics, but we hope to better understand the disease's genetic makeup," he explained. Researchers could eventually perfect tools that help clinicians decide on a course of treatment.

As recently as a few years ago, no one could do this work unless they had a massive budget, as the cost of the work involved in analyzing each sample could run as high as $2,000. The remarkable advances of the last 20 years have made some forms of analysis much more accessible. Today's tools are highly efficient, according to Lemieux, who studied microbiology before specializing in computer science.

Because of the potentially high (and as yet undetermined) number of genes involved, he uses algorithms to teach computers to learn on their own so they can explore the human genome in search of early signs of disease. "This is known as deep learning. It's one of the specialities of the Université de Montréal team led by Yoshua Bengio," he added.

Lemieux hopes to "investigate rare subgroups of and the subtler biological mechanisms involved" through a recently launched research project that brings together several UdeM professors, including Guy Sauvageau, Joseph Paul Cohen and Yoshua Bengio.

He believes that the project will lead to "new observations that will have a real impact on our understanding of the disease."

Explore further: Major breakthrough in developing new cancer drugs: Capturing leukemic stem cells

Related Stories

Major breakthrough in developing new cancer drugs: Capturing leukemic stem cells

March 18, 2014
The Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), in collaboration with the Maisonneuve-Rosemont Hospital's Quebec Leukemia Cell Bank, recently achieved a significant breakthrough ...

Can artificial intelligence be used to study gut microbes in patients?

March 21, 2018
A new Journal of Internal Medicine article proposes that artificial intelligence tools, such as machine learning algorithms, have the potential for building predictive models for the diagnosis and treatment of diseases linked ...

Study leads to breakthrough in better understanding acute myeloid leukemia

May 23, 2017
A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.

Two genes cooperate to trigger leukemia development

March 20, 2018
An international group of researchers led by Prof. Jan Cools of the VIB-KU Leuven Center for Cancer Biology have made a breakthrough in understanding the development of acute lymphoblastic leukemia, an aggressive cancer of ...

New breakthrough in the molecular characterization of acute myeloid leukemia

August 7, 2015
The multidisciplinary team comprising the Leucégène research group, a major project headed by Dr. Guy Sauvageau of the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal and Dr. Josée ...

Neurons have the right shape for deep learning

December 4, 2017
Deep learning has brought about machines that can 'see' the world more like humans can, and recognize language. And while deep learning was inspired by the human brain, the question remains: Does the brain actually learn ...

Recommended for you

Bladder cancer model could pave the way for better drug efficacy studies

May 21, 2018
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients ...

MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas

May 18, 2018
Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas. In their report ...

Particle shows promise to prevent the spread of triple-negative breast cancer

May 18, 2018
USC researchers have pinpointed a remedy to prevent the spread of triple-negative breast cancer. Metastatic breast cancer is a leading cause of death for women. The findings appear today in Nature Communications.

Dilemma for cancer patients as life-saving meds are tied to vision loss

May 18, 2018
(HealthDay)—A newer type of cancer treatment may offer the chance of longer survival, but the drugs could also trigger new side effects, such as vision problems.

Polygenic scores to classify cancer risk

May 18, 2018
Polygenic risk scores could be useful to stratify the risk of several cancers among patients in medical centers, allowing for the potential discovery of new associations between genes, disease and secondary effects, according ...

A way to prevent pancreatic cancer from spreading post-surgery?

May 17, 2018
Scientists at Cold Spring Harbor Laboratory (CSHL) have solved a mystery about how pancreatic cancer spreads following surgery in patients whose tumor is successfully removed. After surgery, patients' typically experience ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.